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Abstract
Purpose: For scanning particle beam therapy, interference between scanning pat-
terns and interﬁeld organ motion may result in suboptimal dose within target vol-
ume. In this study, we developed a simple ofﬂine correction technique for uniform
scanning proton beam (USPB) delivery to compensate for the interplay between
scanning patterns and respiratory motion and demonstrate the effectiveness of our
technique in treating liver cancer.
Methods: The computed tomography (CT) and respiration data of two patients who
had received stereotactic body radiotherapy for hepatocellular carcinoma were used.
In the simulation, the relative beam weight delivered to each respiratory phase is
calculated for each beam layer after treatment of each fraction. Respiratory phases
with beam weights higher than 50% of the largest weight are considered “skipped
phases” for the next fraction. For the following fraction, the beam trigger is regu-
lated to prevent beam layers from starting irradiation in skipped phases by extend-
ing the interval between each layer. To calculate dose‐volume histogram (DVH), the
dose of the target volume at end‐exhale (50% phase) was calculated as the sum of
each energy layer, with consideration of displacement due to respiratory motion and
relative beam weight delivered per respiratory phase.
Results: For a single fraction, D1%, D99%, and V100% were 114%, 88%, and 32%,
respectively, when 8 Gy/min of dose rate was simulated. Although these parameters
were improved with multiple fractions, dosimetric inhomogeneity without motion
management remained even at 30 fractions, with V100% 86.9% at 30 fractions. In
contrast, the V100% values with adaptation were 96% and 98% at 20 and 30 frac-
tions, respectively. We developed an ofﬂine correction technique for USPB therapy
to compensate for the interplay effects between respiratory organ motion and
USPB beam delivery.
Conclusions: For liver tumor, this adaptive therapy technique showed signiﬁcant
improvement in dose uniformity even with fewer treatment fractions than normal
USPB therapy.
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1 | INTRODUCTION
Particle beam therapy has become an important tool in radiation
oncology for cancer treatment due to its improved dose distribution
compared to photon beam treatments.1,2 However, particle beams
are generally more sensitive to organ motion than photon beams.3–5
This sensitivity is more pronounced in medium with inhomogeneity
such as lung and bones, where inter‐ or intrafractional organ motion
may signiﬁcantly change the radiological path length (particle range),
thus affecting delivered dose distribution.
Due to concerns over neutron dose in proton beam, beam scan-
ning has recently become an attractive choice.6–9 However, scanned
beams are more susceptible to the perturbation caused by scanning
motion and interﬁeld organ motion that should be considered.10,11
This interplay typically results in under‐ or overdosage within the
target volume, depending on the motion and scanning pattern. Phil-
lips et al.12 showed that dose uniformity depends on the motion
amplitude relative to the direction of beam motion and target
motion. Lambert et al.13 assessed the interplay for two different scan
directions in proton beam therapy and concluded that target margins
is not effective in compensating for the effects of intrafractional
motion in scanned beam therapy. Furthermore, although range‐based
internal target volume (ITV) is commonly used, complexity of using
ITV for particle therapy has also been reported.14
Recently, several studies have investigated rescanning techniques
to reduce interplay effects to improve dose homogeneity.5,9,15,16 In
this study, we developed a simple ofﬂine correction technique for
uniform scanning proton beam (USPB) delivery to compensate for
the interplay between beam scanning and respiratory motion. Here,
we demonstrate the effectiveness of this technique for treatment of
liver cancer patients.
2 | MATERIALS AND METHODS
2.A | Uniform scanning proton beams
The proton beam used in this study is a nearly continuous beam
with an initial energy of 208 MeV. The vertical scanning frequency
is 144 Hz, whereas the horizontal scanning frequency depends on
the ﬁeld size (i.e., 14.4 Hz for 10 scanning lines). A detailed descrip-
tion of the USPB technique has been described elsewhere.6,7 Unlike
spot scanning for intensity‐modulated proton therapy (IMPT), the
effects of scanning within the iso‐energy layer will be negligible
because the scan speed is much faster than the respiratory cycle. To
produce a uniform spread‐out Bragg peak (SOBP), a range modulator
consisting of binary combination of graphite plates was used to pull‐
back the pristine Bragg peak to different ranges. A 0.5‐s interval is
required to change the energy layer by switching the range
modulator and is accounted for in the calculation. Because beam lay-
ers are pulled back in sequence, a time delay occurs with each beam
delivery, consequently leading to interplay effects with moving
organs.
2.B. | Patients, respiratory motion, and treatment
planning
Under Institutional Review Board (IRB) exemption, the CT and res-
piration data of two patients who received stereotactic body radio-
therapy (SBRT) for hepatocellular carcinoma were used for
simulation. In both cases, the planning target volume (PTV) does
not include air (i.e., lung volume). Because the density of liver and
surrounding soft tissue is uniform, the variation in dose distribution
due to respiratory organ motion is relatively small. Table 1 shows
the size, region, and maximum motion range of target volume. The
gross tumor volume (GTV) was delineated on the four‐dimensional
(4D)‐CT images of the 0%, 25%, 50%, and 75% respiratory phases,
and the contours were copied onto the free‐breathing CT images.
Clinical target volume (CTV) margin was zero. The original PTV for
SBRT treatment was generated by adding a margin to the range‐
based ITV, which was the merged volume of the GTVs. Respiratory
motion of liver tumors were evaluated with orthogonal cine‐MRI
images as shown by Akino et al.17 Sagittal and coronal images were
acquired for 30 s with the same immobilization of treatment to
evaluate the motion amplitude of diaphragm and respiration stabil-
ity. The motion vectors between two continuous images were ana-
lyzed using an optical ﬂow estimation algorithm known as the
pyramidal Lucas–Kanade method.18,19 After cine‐MRI image acquisi-
tions, planning CT and 4D‐CT images were acquired within 15 min.
The 4D‐CT images were sorted into eight respiratory phases. The
phases of 0% and 50% accommodate the end‐inhalation and end‐
exhalation phases, respectively.
TAB L E 1 Characteristics of target volumes and their motion.
Patient # 1 Patient # 2
GTV (cm3) 2.0 31.4
PTV (cm3) 20.6 128.5
Regiona S6 S1
Motion amplitude
AP (mm) 7.4 0.9
LR (mm) 0.6 1.8
SI (mm) 15.7 7.5
GTV, gross tumor volume; PTV, planning target volume; AP, anterior–
posterior; LR, left–right; SI, superior–inferior.
aRegions are shown as the Couinaud classiﬁcation of hepatic segments.
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Treatment plans were generated using Eclipse™ treatment plan-
ning system version 11 (Varian Medical Systems, Palo Alto, CA). The
planning was conducted using the free‐breathing CT images accord-
ing to the SBRT planning procedure in our clinic. The interplay
effects become important, as both organ motion and beam delivery
are accompanied with time‐dependent variations with different fre-
quencies. To evaluate the effects properly, three‐dimensional dose
distribution of each pristine peak is needed. Unfortunately, Eclipse™
does not provide dosimetric data from each layer in the current ver-
sion of the software. We therefore considered a rectangle dose dis-
tribution that includes the original PTV for the sake of simplicity.
We also created multiple rectangular target volumes by varying their
thickness in 5‐mm steps and generated treatment plans for each tar-
get by ﬁtting the size of SOBP to the rectangular target . The layer‐
by‐layer dose distribution data were then obtained by subtracting
each dose distribution from larger one [Figs. 1(a) and 1(b)]. The
weight of each layer was rescaled to obtain uniform SOBP. The
rescaling factor for each layer was determined by checking the pro-
ﬁle of summed dose distribution. To simplify the analysis, plans were
generated with a single beam at a 0° gantry angle. A 10.0‐cm diame-
ter snout was applied. Treatment ﬁelds were collimated with brass
apertures. A single set of scanning beams was generated for each
patient, and special techniques such as rescanning15 were not
applied. The treatment time was assessed for the prescribed dose of
2 Gy/fraction.
2.C. | Ofﬂine adaptation of the beam delivery
Figure 2 illustrates our algorithm of ofﬂine adaptation for the motion
management. Multiple layers of proton beams with various beam‐on
times are delivered in sequence. The relative beam weight of each
layer among respiratory phases varies based on the beam‐on time
and patient respiration. Respiratory‐gated treatment achieves dose
distribution similar to simulation by irradiating only at a speciﬁc res-
piration phase. In our method, however, beam delivery is regulated
to irradiate uniformly among respiratory phases to achieve uniform
dose distribution.
After treatment of each fraction, the relative beam weight deliv-
ered to each respiratory phase is calculated for each beam layer
[Fig. 2(a)]. The beam‐on time depends on the dose rate. For dose
rate of 4 Gy/min, for instance, the beam‐on times of the layer with
the smallest beam weight were 1.580 and 772 s for patient #1 and
#2, respectively. These layers with short beam‐on time are delivered
a part of respiratory cycles, resulting in the inhomogeneous dose dis-
tributions. To detect the respiratory phases that received larger
amount of beam delivery than other phases, the respiratory phases
with beam weights higher than 50% of the largest weight are con-
sidered “skipped phases” in the next fraction. For the following frac-
tion, the beam trigger is regulated to prevent beam layers from
starting irradiation in skipped phases. If beam delivery starts in a
skipped phase, the interval is extended. Although this technique was
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expected to effectively correct the interplay effects especially for
beams with small weight, this may not work for beams with large
weights because long beam‐on time results in the uniform distribu-
tion of beam delivery among respiratory phases. If the correction
successfully achieved uniform distribution of beam delivery after
multiple fractions, the correction may not work even for beams with
short weight. To overcome this problem, the threshold of 50% was
changed to 70% if the beam weight of all phases exceeds 50% of
the largest value. If the weights of all phases are higher than 70% of
the largest value, adaptation is not applied. In such a case, at the
“Adaptation” branched structure in the ﬂowchart, the procedure will
go to beam‐on. When all layers have been delivered, the relative
beam weights among respiratory phases and skipped phases are
updated for subsequent fractions. This algorithm regulates only the
interval between beam layers for delivery.
2.D. | Evaluation of motion interplay effects
To calculate the dose‐volume histogram (DVH), the GTV on the 50%
(end‐exhalation) phase of 4D‐CT was evaluated, as patient respira-
tion is most stable in this phase.20 Instead of evaluating range‐based
ITV, which is a merged volume at each phase, the GTV was moved
along the respiratory motion vector, and the average of dose at each
position was evaluated for each voxel of GTV. The GTV dose was
calculated as the sum of each energy layer with compensation for
displacement due to respiratory motion and relative beam weight
delivered in each respiratory phase [Fig. 1(c)]. The Di, which is the
dose delivered to a voxel of target with the 3D coordinates of Xi,
was calculated using the following formula:
Di ¼ ∑nk∑8t¼1fDkðXi; δtÞ Wtg (1)
where Dk represents the dose of the pristine peak of the kth energy
layer; δt represents the displacement vector due to the respiratory
motion at the respiration phase, t; andWt represents the weight of the
beam‐on time for phase t. Unlike deformable image registration tech-
nique,21 this method cannot consider rotation or deformation of
tumors for cumulative dose calculation. However, this technique is not
accompanied by uncertainties regarding the accuracy of dose warping.
The calculated DVH varies with the initial phase of beam deliv-
ery, even if the same respiration data are evaluated. To obtain statis-
tically reliable data, we calculated DVH 500 times. For each
iteration, the initial time of starting treatment for each fraction was
determined by equally distributed random numbers. To evaluate the
total DVH, the dose at each fraction was averaged for each voxel.
Therefore, DVH calculation was performed for fraction number mul-
tiplied by 500 (i.e., 15 000 times for 30 fractions). The results also
vary with the beam‐on time. Under the reference conditions of our
system (10 cm cone, energy range of 16 cm, and SOBP of 10 cm), a
2 nA beam current represents a dose rate of almost 2 Gy/min. In the
current study, the dose rate for the entire SOBP was assumed to be
2, 4, and 8 Gy/min, and the beam‐on time of each energy layer was
calculated by multiplying relative beam weights.
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Homogeneity index (HI) deﬁned in International Commission on
Radiation Units and Measurements (ICRU) report No. 8322 was cal-
culated as follows:
HI ¼ D2%  D98%
D50%
(2)
where D2%, D50%, and D98% represent doses of 2%, 50%, and 98%
target volume, respectively.
3 | RESULTS
Figures 3(a), 3(b) illustrate examples of the relative beam weights
of beam delivery among each respiratory phase calculated for 10
fractions at a dose rate of 8 Gy/min. Layer 1 with the highest
proton energy and longest beam‐on time shows uniform beam
weight both with and without adaptation. However, other layers
with shorter beam‐on time showed inhomogeneous beam weight
without adaptation. In contrast, when adaptation was applied, all
layers showed more uniform beam weights than those without
adaptation, even for layer G, which had the shortest beam‐on
time. In Figures 3(c), 3(d), the standard deviation (SD) of beam
weight among each respiratory phase calculated for the 8 Gy/min
dose rate was plotted against fraction number, and median values
of 500 iterative calculations are illustrated. SD values were larger
for layers with short beam‐on time than long. Although data
from runs both with and without adaptation showed
fraction‐dependent decreases in SD, plans with adaptation
showed a much more rapid decrease with increasing fraction
number than those without.
Figure 4 shows the range of variation in DVH calculated 500
times for 2 and 8 Gy/min dose rates. The DVH for the 2 Gy/min
dose rate was steeper than that for the 8 Gy/min dose rate, which
showed large variation with a higher maximum dose and lower mini-
mum dose than the 2 Gy/min dose rate, representing hot and cold
spots. In contrast, the histogram of patient #2 showed little differ-
ence between 2 and 8 Gy/min dose rates.
Figure 5 illustrates a dose of 1% (D1%) and 99% (D99%) in patient
#1, representing values similar to the maximum and minimum doses,
respectively. Figures 6(a), 6(b) shows the HI. The 5th and 95th per-
centile values, which represent values 25th and 475th from the low-
est of 500 iterative DVH calculations, respectively, are shown in
Figs. 5 and 6). For single fraction, values 114% of D1% and 88% of
D99% were observed for the 8 Gy/min dose rate. Although the D1%
and D99% improved with increasing fraction number, inhomogeneity
of the 8 Gy/min plan without adaptation remained even at 30
fractions.
In contrast, plans with adaptation showed signiﬁcant improve-
ment in dose uniformity with increasing number of fractions. Fig-
ures 6(c) and 6(d) show the volume receiving 100% of the
prescribed dose (V100%). For single fraction, V100% of the 8 Gy/min
plan was 32%, and while the value improved with increasing number
of fractions, V100% was still 86.9% at 30 fractions. In contrast, plans
with adaptation showed greater improvement than those without
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(Figs. 5 and 6), with V100% values in 8 Gy/min plans of 96% and 98%
at 20 and 30 fractions, respectively.
Treatment times, including beam‐on time and intervals of plans
without adaptation, were 63.5, 33.45, and 18.5 s for 2, 4, and
8 Gy/min dose rate, respectively. Mean ± SD differences in treat-
ment time between plans with and without adaptation were
3.6 ± 1.1, 5.1 ± 1.1, and 4.6 ± 0.8 s for 2, 4, and 8 Gy/min,
respectively.
4 | DISCUSSION
In this study, we simulated the interplay effects between liver tumor
motion and beam delivery in USPB. For each fraction, the homo-
geneity of the delivered dose distribution was poor and correlated
with dose rate. Such dose errors in each fraction will be averaged
out over multiple fractions, as demonstrated in Figures 5–6.
Although hot and cold spots decreased by averaging dose
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distribution with multiple fractions, the common 20–30 fractions in a
treatment still showed consistent inhomogeneity. We also demon-
strated that ofﬂine correction of beam delivery by regulating inter-
vals between each energy layer markedly improved dose
homogeneity at a lower number of fractions than normal USPB ther-
apy. Although the beneﬁts of adaptation seem modest for a dose
rate of 2 Gy/min, improvement in V100% was still observed. Generally
the layer with highest energy is delivered with the longest beam‐on
time. Although biological uncertainties may remain, due to an inho-
mogeneous dose being delivered to the target in the initial few frac-
tions, doses at cold or hot spots are not expected to be extremely
low or high given the substantial contribution of the beam with the
highest energy.
To overcome the effects of organ motion, the gating technique23
has been used for moving targets, such as lung24,25 and liver26
tumors. Based on a signal from a motion‐monitoring device, the
beam is delivered only during speciﬁc parts of the breathing cycle.
Since exhalation is the most reproducible respiratory state, the end‐
exhalation phase is often selected as the gating window.27 For ion
beams including proton and carbon beams, the rescanning technique
has been investigated in an effort to reduce dose inhomogene-
ity.5,15,16 In this technique, treatment delivery is repeated N times
within each fraction, with the number of particles reduced to 1/N
per rescan. Multiple scans will lead to an averaging effect of the
interference pattern if it can be ensured that the motion parameters
such as initial phase or respiratory cycle differ for each rescan. Furu-
kawa et al.28 showed that the phase‐controlled rescanning method
with a large number of rescans improved dose delivery for moving
targets. The beneﬁts of the gating technique include minimized inter-
play effects and potential to reduce ﬁeld sizes, leading to desired
dose delivery to target. However, treatment time increases with gat-
ing due to the frequent interruption of the beam. The ofﬂine adapta-
tion proposed in this study is simple with active correction, and the
difference in treatment time between plans with and without correc-
tion is less than 10 s. The baseline shift of patient respiration results
in inappropriate beam delivery and often prolongs the treatment
time of gating radiotherapy.29 In contrast, the baseline shift will not
greatly affect our method, especially in terms of treatment time.
With this correction technique, uniform dose delivery will be achiev-
able without reducing efﬁciency of treatment due to elongated treat-
ment time.
For the technique presented in this study, a real‐time monitoring
of tumor position is needed. A CyberKnife robotic radiosurgery sys-
tem (Accuray, Accuray, Inc., Sunnyvale, CA) enables irradiations with
real‐time tumor tracking with a Synchrony™ system.30,31 The Syn-
chrony system generates a correlation model between the tumor
position determined by orthogonal KV x‐ray images and surrogate
LED markers placed on the patient chest or abdomen. During treat-
ment, the system keeps monitoring the surrogate LED markers and
predicts the tumor position 115 ms ahead of time. Such technology
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will be helpful for beam regulation with patient respiration. For pro-
ton beam therapy, surrogate markers placed on patient chest or
abdomen to detect respiration signal may affect the dose distribu-
tions. A laser‐based or optical camera‐based devises will be able to
provide the signal without affecting the proton beam delivery.32 In
clinical practice, the range of the ion beam will be affected by den-
sity variations, especially in regions including air and ribs. Here, we
excluded cases with liver tumors near diaphragm dome and exam-
ined patients whose PTV volumes did not include air. For lung can-
cer treatment, dose calculation will be necessary for each respiratory
phase of 4D‐CT. Because the tissue surrounding a liver tumor is
solid and the density uniform, the variation in dose distribution due
to respiratory motion will be small. However, skin motion due to res-
piration may also affect the dose distribution, leading to an increase
in uncertainties in this study.
With respect to scan direction, several reports have suggested
that scanning planes should be perpendicular to the motion direc-
tion.13,33 In the present study, treatment plans were created using
a single beam to generate various sizes of SOBP. Therefore, the
dose variation in the lateral and superior–inferior directions is very
small, resulting in an underestimation of interplay effects. As shown
in Table 1, the motion in the anterior–posterior and lateral direction
of patient # 2 is less than 2 mm, resulting in small motion effects.
In addition, the target volume of patient #2 is much larger than
that of patient #1. In an actual treatment, longer beam‐on time due
to a large target volume may lead to modest interplay effects. Gen-
erally, two or more beams are used for proton therapy. If two
orthogonal beams are used with our methodology, the interplay
effects observed in one beam may not appear in another beam
because of simple dose distribution. However, if a compensator is
applied to the distal edge of a sphere‐shaped target volume, the
interplay effects could become more complex and larger, due to
the complex dose distribution of each layer. In such cases, motion
management may be the choice of treatment to ensure accurate
proton therapy.
5 | CONCLUSION
We have developed an ofﬂine correction technique for USPB ther-
apy to compensate for the interplay effects between respiratory
organ motion and layer‐by‐layer beam delivery. For the treatment of
liver tumors, this adaptive therapy technique showed a signiﬁcant
improvement in dose uniformity with fewer treatment fractions.
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